Anticoagulant therapy for patients with atrial fibrillationin in special situations: diabetes mellitus and/or chronic kidney disease | Zendy

S. G. Кanorskiy | Zendy

Open Access

Anticoagulant therapy for patients with atrial fibrillationin in special situations: diabetes mellitus and/or chronic kidney disease

Author(s) -

S. G. Кanorskiy

Publication year - 2018

Publication title -

kardiologiia

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.159

H-Index - 16

eISSN - 2412-5660

pISSN - 0022-9040

DOI - 10.18087/cardio.2469

Subject(s) - medicine , atrial fibrillation , antithrombotic , diabetes mellitus , kidney disease , anticoagulant therapy , anticoagulant , cardiology , thromboembolic stroke , intensive care medicine , disease , endocrinology

Conducting anticoagulant therapy for atrial fibrillation, combined with diabetes mellitus and/or chronic kidney disease, can create certain difficulties for practicing doctors due to a simultaneous increase in the risk of thromboembolic and hemorrhagic complications. The presence of diabetes mellitus and renal dysfunction can influence the results of antithrombotic therapy in patients with atrial fibrillation. The review provides information on the differences in efficacy and safety of individual oral anticoagulants in the prevention of thromboembolic complications of atrial fibrillation in patients with diabetes mellitus, impaired renal function.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research